AU2000275033A1 - Use of inos inhibitors for treating or preventing myopia - Google Patents
Use of inos inhibitors for treating or preventing myopiaInfo
- Publication number
- AU2000275033A1 AU2000275033A1 AU2000275033A AU7503300A AU2000275033A1 AU 2000275033 A1 AU2000275033 A1 AU 2000275033A1 AU 2000275033 A AU2000275033 A AU 2000275033A AU 7503300 A AU7503300 A AU 7503300A AU 2000275033 A1 AU2000275033 A1 AU 2000275033A1
- Authority
- AU
- Australia
- Prior art keywords
- treating
- inos inhibitors
- preventing myopia
- myopia
- inos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2000/000284 WO2002024250A1 (en) | 2000-09-20 | 2000-09-20 | Use of inos inhibitors for treating or preventing myopia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2000275033A1 true AU2000275033A1 (en) | 2002-04-02 |
Family
ID=4574701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2000275033A Abandoned AU2000275033A1 (en) | 2000-09-20 | 2000-09-20 | Use of inos inhibitors for treating or preventing myopia |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1399547A (en) |
| AU (1) | AU2000275033A1 (en) |
| WO (1) | WO2002024250A1 (en) |
-
2000
- 2000-09-20 AU AU2000275033A patent/AU2000275033A1/en not_active Abandoned
- 2000-09-20 CN CN00815738A patent/CN1399547A/en active Pending
- 2000-09-20 WO PCT/CN2000/000284 patent/WO2002024250A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002024250A1 (en) | 2002-03-28 |
| CN1399547A (en) | 2003-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001260400A1 (en) | Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders | |
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU2002219472A1 (en) | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens | |
| AU7906100A (en) | Use of retigabin for treating neuropathic pain | |
| AU2002215261A1 (en) | Method and arrangement for treatment of fluid | |
| AU3998400A (en) | Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor | |
| AU2002248269A1 (en) | Use of p38 inhibitors for the treatment of inflammation-enhanced cough | |
| AU2001286983A1 (en) | Method of treatment | |
| AU2001277534A1 (en) | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity | |
| AU2002237667A1 (en) | Methods for the treatment and prevention of urinary stone disease | |
| AU2002232400A1 (en) | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis | |
| AU2001266838A1 (en) | Inhibitors of matriptase for the treatment of cancer | |
| AU2001240046A1 (en) | Method of treating skin conditions | |
| AU2001232060A1 (en) | Use of cyp1b1 inhibitors for treating cancer | |
| HUP0302430A3 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience | |
| AU2002233210A1 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence | |
| AU2002349268A1 (en) | Medicine for preventing and treating bromidrosis | |
| AU2001264522A1 (en) | Methods and compositions for the prevention of myopia | |
| AUPQ582400A0 (en) | A method of treatment and agents for use therein | |
| AU2002233209A1 (en) | Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
| AU2001262177A1 (en) | Method of treatment | |
| AU2000275033A1 (en) | Use of inos inhibitors for treating or preventing myopia | |
| AU2619199A (en) | Treatment of waxes | |
| AU4598400A (en) | Method of treatment | |
| AU4021700A (en) | Methods of use of beta1-integrin inhibitors |